← Open Payments lookup

ALISON SCHAEFER: Open Payments

NPI 1932198553 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,566 in 74 payments from 15 companies in 2025. Trend: 2023 $759 · 2024 $1,090 · 2025 $1,566

Food & beverage: $1,566
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP17$324
GlaxoSmithKline, LLC.14$242
Novartis Pharmaceuticals Corporation12$231
Regeneron Healthcare Solutions, Inc.9$226
ARS Pharmaceuticals Operations, Inc.6$139
Genentech USA, Inc.2$64
CSL Behring2$59
Takeda Pharmaceuticals U.S.A., Inc.2$59
Boston Scientific Corporation2$54
GENZYME CORPORATION2$53

Products named: DUPIXENT, FASENRA, NUCALA, NEFFY, TEZSPIRE, XOLAIR, TRELEGY ELLIPTA, Rhapsido.

Industry payments across VA — which companies pay providers there.